欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0643/001
药品名称Metoject
活性成分
    • Methotrexate disodium 50.0 mg/ml
剂型Solution for injection in prefilled syringe
上市许可持有人medac Gesellschaft für klinische Spezialpräparate mbH, Germany
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Latvia (LV)
    • Czechia (CZ)
    • Germany (DE)
      Metex 50mg/ml Injektionslösung
    • Denmark (DK)
    • Belgium (BE)
    • Austria (AT)
      Metoject 50 mg/ml Injektionslösung in einer Fertigspritze
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Lithuania (LT)
      Metex 50 mg/ml injekcinis tirpalas užpildytame švirkšte
    • Estonia (EE)
      METEX
    • Hungary (HU)
      METOJECT 50 mg/ml oldatos injekció előretöltött fecskendőben
    • Slovakia (SK)
      Metoject 50 mg/ml injekčny roztok
    • Slovenia (SI)
    • Iceland (IS)
      Metoject 50 mg/ml Stungulyf, lausn í áfylltri sprautu
    • Netherlands (NL)
许可日期2008/10/02
最近更新日期2024/12/18
药物ATC编码
    • L04AX03 methotrexate
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase